immature dendritic cell therapy (Recalcine/Pontifical Catholic University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameimmature dendritic cell therapy (Recalcine/Pontifical Catholic University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionImmunomodulatorsT lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryChile
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecalcine Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecalcine Pharmaceutical CorpPontificia Universidad Catolica De Chile
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A